In contrast, a group of patients with milder symptoms, classified as Non-Classic CF by established guidelines [7], [8], [10], evidenced residual CFTR-mediated Cl− secretion (10 to 57%), consistently with our previous data [18]. This evidence concerns the gene CFTR and cystic fibrosis.